| Recruitment status | No longer recruiting |
| Unique ID issued by UMIN | UMIN000032654 |
| Receipt No. | R000037233 |
| Scientific Title | Indocyanine green fluorescence imaging to reduce the risk of anastomotic leakage in laparoscopic low anterior resection for rectal cancer: A Large, Multicenter, Propensity Score Matched Cohort Study |
| Date of disclosure of the study information | 2018/05/21 |
| Last modified on | 2022/05/24 (Ver. 2) |
| Basic information | ||
| Public title | Indocyanine green fluorescence imaging to reduce the risk of anastomotic leakage in laparoscopic low anterior resection for rectal cancer: A Large, Multicenter, Propensity Score Matched Cohort Study | |
| Acronym | Fluorescence imaging in laparoscopic low anterior resection | |
| Scientific Title | Indocyanine green fluorescence imaging to reduce the risk of anastomotic leakage in laparoscopic low anterior resection for rectal cancer: A Large, Multicenter, Propensity Score Matched Cohort Study | |
| Scientific Title:Acronym | Fluorescence imaging in laparoscopic low anterior resection | |
| Region |
|
|
| Condition | |||
| Condition | Rectal cancer | ||
| Classification by specialty |
|
||
| Classification by malignancy | Malignancy | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | The aim of this study was to evaluate the effect of ICG fluorescence imaging (ICG-FI) on AL rates during laparoscopic low anterior resection (LAR) for rectal cancer, compared to a propensity score matched series of laparoscopic LAR performed without ICG-FI. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The primary endpoint of this study was the rate of AL within 30 days after surgery. |
| Key secondary outcomes | Secondary endpoints were operative time, blood loss, postoperative complications, reoperation within 30 days after surgery, length of hospital stays, oncological clearance, and the rate of changing the surgical plan. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Eligibility criteria were 1) rectal cancer located within 15 cm from anal verge with histologically proven adenocarcinoma or signet-ring cell carcinoma and 2) having undergone primary rectal cancer resection. | |||
| Key exclusion criteria | The exclusion criteria were 1) multiple primary cancers, 2) a history of treatment for other pelvic malignancy, 3) open or robotic surgery cases, and 4) emergent cases. | |||
| Target sample size | 600 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Yokohama City University Medical Center, Yokohama, Japan | ||||||
| Division name | Department of Surgery, Gastroenterological Center | ||||||
| Zip code | 232-0024 | ||||||
| Address | 4-57, Urafune-cho, Minami-ku, Yokohama, 232-0024. Japan | ||||||
| TEL | 045-261-5656 | ||||||
| jun0926@yokohama-cu.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Yokohama City University Medical Center, Yokohama, Japan | ||||||
| Division name | Department of Surgery, Gastroenterological Center | ||||||
| Zip code | 232.0024 | ||||||
| Address | 4-57, Urafune-cho, Minami-ku, Yokohama, 232-0024. Japan | ||||||
| TEL | 045-261-5656 | ||||||
| Homepage URL | |||||||
| jun0926@yokohama-cu.ac.jp | |||||||
| Sponsor | |
| Institute | Yokohama City University Medical Center, Yokohama, Japan |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Self funding |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Y-NEXT IRB |
| Address | 1-1-1, Fukuura, Kanazawa-ku, Yokohama, 236-0004. Japan |
| Tel | 045-370-7976 |
| rinri@yokohama-cu.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | No longer recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB | |||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | This retrospective multi-institutional study was conducted to evaluate the AL rates after laparoscopic LAR for rectal cancer at three institutions of Yokohama Clinical Oncology Group in Japan from September 2014 to December 2017. The study protocol was approved by the Ethical Advisory Committee of Yokohama City University Medical Center and the institutional review board of each participating hospital before the study was initiated. Patient data were collected from clinical report forms. Eligibility criteria were 1) rectal cancer located within 15 cm from anal verge with histologically proven adenocarcinoma or signet-ring cell carcinoma and 2) having undergone primary rectal cancer resection. The exclusion criteria were 1) multiple primary cancers, 2) a history of treatment for other pelvic malignancy, 3) open or robotic surgery cases, and 4) emergent cases. The primary endpoint of this study was the rate of AL within 30 days after surgery. Secondary endpoints were operative time, blood loss, postoperative complications, reoperation within 30 days after surgery, length of hospital stays, oncological clearance, and the rate of changing the surgical plan. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000037233 |